Press Release Archives - 2010
2010
Kane Biotech receives $100,000 in financial assistance from the Government of Manitoba
December 15, 2010
Kane Biotech Announces Closing of Private Placement Offering
December 1, 2010
Kane Biotech Issued US Patent for DispersinB® Wound Care Technology
November 16, 2010
DispersinB® Topical Wound Spray Passes Critical Sensitization Test
November 8, 2010
Kane Biotech Appoints Board Advisor and Announces Private Placement Offering
November 2, 2010
Kane Biotech selected as one of Canada's Top 10 Life Sciences Companies
October 14, 2010
DispersinB® Wound Spray Passes First Set of Biocompatibility Tests
October 4, 2010
DispersinB® Wound Spray Passes Quality Control and Sterility Tests
September 30, 2010
Kane Biotech Announces Grant of Options
September 29, 2010
Kane Biotech Develops DispersinB® Monoclonal Antibodies
September 21, 2010
Kane Biotech Appoints Mr. Philip Renaud to Board of Directors
September 15, 2010
Kane Biotech Appoints Dr. Jeffrey B. Kaplan to Scientific Advisory Board
July 20, 2010
DispersinB® Technology for Development of Disease Resistant Biotech Crops
June 29, 2010
Kane Biotech's Antibiofilm Technologies Published in Two New Scientific Books
February 23, 2010
Kane Biotech Announces Grant of Options
January 22, 2010
DispersinB® Patent Issues in Australia
January 20, 2010